Skip to main content

LABCORP HOLDINGS INC. (LH) Stock Forecast 2025 - AI Price Prediction & Analysis


LABCORP HOLDINGS INC. (LH) AI Stock Price Forecast & Investment Analysis

LABCORP HOLDINGS INC. Stock Price Chart and Technical Analysis

Loading LABCORP HOLDINGS INC. interactive price chart and technical analysis...

LABCORP HOLDINGS INC. (LH) - Comprehensive Stock Analysis & Investment Research

Deep dive into LABCORP HOLDINGS INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about LABCORP HOLDINGS INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For LABCORP HOLDINGS INC.: LABCORP HOLDINGS INC. operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

LABCORP HOLDINGS INC. (Stock Symbol: LH) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Medical Laboratories industry.

The organization employs approximately 61000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing LABCORP HOLDINGS INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LABCORP HOLDINGS INC.: With $13483M in annual revenue and 3.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $13483 million generating a 3.6% net profit margin .

Market Capitalization: $23520 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 20.2% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for LABCORP HOLDINGS INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For LABCORP HOLDINGS INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for LABCORP HOLDINGS INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: LABCORP HOLDINGS INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For LABCORP HOLDINGS INC.: Strong free cash flow generation demonstrates exceptional operational efficiency.

LABCORP HOLDINGS INC. strategically competes in the highly dynamic Services-Medical Laboratories marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $1825 million annually, complemented by impressive 47.8% year-over-year cash flow growth.

The company maintains a healthy 28.6% gross margin, indicating strong pricing power and operational efficiency.

LABCORP HOLDINGS INC. (LH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for LABCORP HOLDINGS INC. stock analysis.

Loading LABCORP HOLDINGS INC. comprehensive fundamental analysis and insider trading data...

Deep dive into LABCORP HOLDINGS INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if LABCORP HOLDINGS INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For LABCORP HOLDINGS INC.: With a P/E ratio of 30.81, the market highly values future growth prospects.

P/E Ratio 30.81x
P/B Ratio 2.78x
Market Cap $23520M
EPS $9.14
Book Value/Share $102.20
Revenue/Share $162.65
FCF/Share $15.52
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently LABCORP HOLDINGS INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LABCORP HOLDINGS INC.: An ROE of 20.2% demonstrates excellent shareholder value creation.

ROE 20.2%
ROA 10.2%
ROIC 13.5%
Gross Margin 28.6%
Operating Margin 6.2%
Net Margin 3.6%
EBT Margin 17.3%
Tax Rate 23.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess LABCORP HOLDINGS INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For LABCORP HOLDINGS INC.: A current ratio of 1.98 shows adequate liquidity.

Current Ratio 1.98x
Quick Ratio 1.62x
D/E Ratio 0.57x
Financial Leverage 1.93x
Interest Coverage 14.3x
Working Capital $2047M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal LABCORP HOLDINGS INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For LABCORP HOLDINGS INC.: Free cash flow of $1825M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $2308M
Free Cash Flow $1825M
Capital Spending $-482M
OCF Growth YoY 47.8%
FCF Growth YoY 67.9%
FCF/Sales 11.5%
CapEx/Sales 3.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively LABCORP HOLDINGS INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For LABCORP HOLDINGS INC.: An asset turnover of 0.77x suggests room for improvement in asset utilization.

Asset Turnover 0.77x
Receivables Turnover 7.0x
Inventory Turnover 24.4x
Fixed Assets Turnover 5.8x
Days Sales Outstanding 53 days
Days Inventory 15 days
Payables Period 21 days
Cash Conversion Cycle 46 days
Understanding Financial Statement Data

What these metrics mean: Key figures from LABCORP HOLDINGS INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For LABCORP HOLDINGS INC.: With annual revenue of $13483M, LABCORP HOLDINGS INC. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $13483M
SG&A Expense $13M
Cost of Goods Sold $1786M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 25%
Cash & Short-term Investments 6%
Total Liabilities 48%
Short-term Debt 0%
Accounts Receivable 15%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 83M
Growth Metrics (YoY)
EPS Growth 2.1%

Latest LABCORP HOLDINGS INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting LABCORP HOLDINGS INC. (LH) stock price and investment outlook.

, source: Seeking Alpha

Good day, and thank you for standing by. Welcome to Labcorp's Fourth Quarter 2024 Conference Call [Operator Instructions]. Please be advised today's conference being recorded. I would now like to hand ...

, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

, source: BioWorld

Nowdiagnostics Inc. established an exclusive agreement with Labcorp Holdings Inc. for distribution of its First To Know syphilis test in the U.S. The test provides results in 15 minutes with as little ...

LABCORP HOLDINGS INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of LABCORP HOLDINGS INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADVB Unlock Forecast - 30 Days FREE Trial $10M x 2.5x
BDSX Unlock Forecast - 30 Days FREE Trial $941M -3.0x 827.0x
BNR Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CAI Unlock Forecast - 30 Days FREE Trial $8981M 7.6x 19.8x
CDNA Unlock Forecast - 30 Days FREE Trial $767M 14.8x 2.3x
CELC Unlock Forecast - 30 Days FREE Trial $2038M -4.5x 45.9x
CSTL Unlock Forecast - 30 Days FREE Trial $642M -2110.5x 1.4x
DGX Unlock Forecast - 30 Days FREE Trial $21111M 22.2x 2.9x
EXAS Unlock Forecast - 30 Days FREE Trial $11586M -343.6x 4.7x
FLGT Unlock Forecast - 30 Days FREE Trial $694M 516.8x 0.6x
FTRE Unlock Forecast - 30 Days FREE Trial $858M -6.8x 1.5x
GH Unlock Forecast - 30 Days FREE Trial $8399M -8.9x -23.0x
GRAL Unlock Forecast - 30 Days FREE Trial $3037M x 1.3x
LH Unlock Forecast - 30 Days FREE Trial $23520M 30.8x 2.8x
NTRA Unlock Forecast - 30 Days FREE Trial $24537M -74.2x 19.7x
PMDI Unlock Forecast - 30 Days FREE Trial $13M x 2.5x
PSNL Unlock Forecast - 30 Days FREE Trial $809M -2.3x 4.2x
RDNT Unlock Forecast - 30 Days FREE Trial $5809M 462.8x 6.2x
RENXF Unlock Forecast - 30 Days FREE Trial $13M x x
RNLXY Unlock Forecast - 30 Days FREE Trial $45M x x
SERA Unlock Forecast - 30 Days FREE Trial $146M -9.0x 1.7x
VCYT Unlock Forecast - 30 Days FREE Trial $2791M 106.0x 2.3x
XGN Unlock Forecast - 30 Days FREE Trial $254M -5.4x 12.1x

Frequently Asked Questions - LABCORP HOLDINGS INC. Stock Forecast

How accurate are LABCORP HOLDINGS INC. stock predictions?

Our AI model demonstrates 63% historical accuracy for LH predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence LABCORP HOLDINGS INC. stock price forecasts?

Our analysis considers LABCORP HOLDINGS INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is LABCORP HOLDINGS INC. a good investment in 2025?

Based on our AI analysis, LABCORP HOLDINGS INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are LABCORP HOLDINGS INC. forecasts updated?

LABCORP HOLDINGS INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced LABCORP HOLDINGS INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for LABCORP HOLDINGS INC. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...